 |
市场调查报告书
商品编码
1197771
眼部整形手术市场-增长、趋势和预测 (2023-2028)Oculoplastic Surgery Market - Growth, Trends, and Forecasts (2023 - 2028) |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
在预测期内，眼部整形手术市场的复合年增长率预计为 5.5%。
由于世界各地政府当局实施的预防性关闭和其他限制措施，其各自的製造和供应链运营中断，全球外科手术市场受到了负面影响。 此外，由于整体经济形势受到大流行的严重影响，随着削减非必要支出的趋势增加，消费者需求下降。 预计上述因素将在预测期内影响全球眼科骨科市场的收入轨迹。 这可能是由于与眼睛有关的疾病、与年龄有关的眼部整形手术和技术进步的增加。 例如，2021 年 8 月，根据国家医学图书馆的数据，造成全球眼病负担的因素是屈光不正（2770 万 DALY）、白内障（1770 万 DALY）、黄斑变性（930 万 DALY），其中包括青光眼（ 470 万 DALYs）和沙眼（130 万 DALYs）。 因此，眼部相关疾病的增加正在推动所研究市场的增长。
随着老龄化社会的发展，与面部和眼睑相关的疾病将会增加，因此市场有望增长。 例如，根据世界卫生组织 (WHO) 的数据，到 2030 年，世界上六分之一的人将超过 60 岁。 届时，据说60岁及以上人口的比例将从2020年的10亿增加到14亿。
市场上的主要参与者正专注于眼科整形手术中使用的人工晶状体和眼科整形手术设备等监管提交，这将在预测期内推动全球眼科整形手术市场的增长。预计将推动 例如，2021 年 4 月，美国眼保健产品公司博士伦公司获得美国食品和药物管理局 (FDA) 的批准，其 ClearVisc 是一种用于眼科整形手术的分布式眼科粘弹性手术设备 (OVD)。 ClearVisc 含有山梨糖醇，可在白内障手术期间防止自由基。 此外，强生视力公司于 2021 年 2 月推出了 TECNIS Eyhance，这是一种单焦点人工晶状体 (IOL)，可用于散光和非散光患者的白内障手术，散光是眼睛曲率的缺陷。Toric II 已获得批准美国食品和药物管理局 (FDA)。
然而，高昂的手术费用和缺乏报销政策可能会在一定程度上阻碍市场增长。
眼科整形手术的市场趋势
眼科整形重睑术未来有望健康成长
随着全球眼睑手术数量的增加，眼睑手术领域有望在未来实现健康发展。 例如，根据美国整形外科学会的数据，估计 2021 年全球将进行 130 万例眼睑手术。 双眼皮手术，也称为眼部拉皮术或眼睑成形术，去除上眼睑多余的皮肤并减少下眼睑的眼袋。
根据美国整形外科医师学会的说法，眼睑手术通常是出于美容原因。 据透露，眼睑成形术是男性和女性最受欢迎的五种手术之一，也是 65 岁以上患者中最受欢迎的手术之一。 眼睑成形术是一种去除眼睑多余皮肤的外科手术。 随着年龄的增长，我们的眼睑会变长，支撑眼睑的肌肉也会变弱。 结果，多余的皮肤和脂肪堆积在眼睑上方和下方。 这会导致眉毛下垂、上眼睑下垂和眼袋。 除了老化之外，眼睛周围皮肤的严重下垂会降低侧视（周边视力），尤其是视野的上部和外部。 眼睑成形术可以减少或消除这些视力问题。 此外，这种手术可以使您的眼睛看起来更年轻、更机敏。
因此，眼睑手术的好处和老年人口的增加正在推动所研究市场的增长。
预计在预测期内北美将占据很大的市场份额
由于人口老龄化、可支配收入增加以及愿意在整容手术上花钱，预计北美将在全球眼部整形手术市场占据重要市场份额。 根据美国骨科医师学会的数据，2021 年美国将进行约 2300 万次整形手术，从而推动该地区的市场发展。
意识的提高和医疗基础设施的发展将推动该地区的市场。 眼科医生使用激光和微型角膜刀进行 LASIK 手术，重塑眼睛的角膜以改善视力。 到 2021 年，将有大约 1200 万美国人接受 LASIK 手术。 到 45-55 岁，老花眼的患病率在北美估计接近 80%，其中 16.5% 估计矫正不当。
全世界有 4000 万人接受了 LASIK 手术。 在美国，超过 1000 万美国人选择了这种治疗方法来改善他们的视力和生活质量。 据说在 2020 年，美国有 718,000 人选择了 LASIK 手术来放弃眼镜和隐形眼镜。
此外，不断增长的医疗旅游、不断增加的医疗支出以及成熟的医疗基础设施也在显着推动整个北美市场的增长。 2021 年 4 月，根据美国国家医学图书馆的数据，许多美国患者正前往巴西、阿根廷和哥斯达黎加等拉丁美洲国家进行美容治疗，在那里他们可以经济高效地旅行并接受先进的整容手术程序。这是可能是因为你可以使用 墨西哥是需要初级和牙科护理的美国患者的热门旅游目的地。
因此，上述因素正在推动该地区的市场增长。
光学整形市场竞争者分析
眼部整形手术市场竞争适中，由几家大型企业组成。 目前主导市场的公司包括 Sklar Surgical Instruments、TEKNO-MEDICAL Optik-Chirurgie GmbH、Zimmer Biomet Holdings Inc、Integra Life Science、B. Braun Melsungen AG、Katena (Blink Medical Ltd)、Karl Storz、Bolton Surgical Ltd、Stanford Health Care , Blink 医疗有限公司等。
其他好处
- Excel 格式的市场预测 (ME) 表
- 三个月的分析师支持
内容
第一章介绍
- 研究假设和市场定义
- 调查范围
第二章研究方法论
第 3 章执行摘要
第四章市场动态
- 市场概览
- 市场驱动因素
- 眼睛相关疾病的增加
- 眼科整形手术随着年龄的增长而增加
- 技术进步
- 市场製约因素
- 手术费用上涨且报销不足
- 波特的五力分析
- 新进入者的威胁
- 买方/消费者议价能力
- 供应商的议价能力
- 替代品的威胁
- 竞争公司之间的敌对关係
第 5 章市场细分（基于价值的市场规模 - 百万美元）
- 按手术类型
- 双眼皮手术
- 提眉和提额
- 整容
- 小儿眼科整形外科
- 其他手术类型
- 最终用户
- 医院
- 门诊手术中心
- 其他最终用户
- 按地区细分
- 北美
- 美国
- 加拿大
- 墨西哥
- 欧洲
- 德国
- 英国
- 法国
- 意大利
- 西班牙
- 其他欧洲地区
- 亚太地区
- 中国
- 日本
- 印度
- 澳大利亚
- 韩国
- 其他亚太地区
- 中东
- 海湾合作委员会
- 南非
- 其他中东地区
- 南美洲地区
- 巴西
- 阿根廷
- 其他南美洲
- 北美
第六章竞争格局
- 公司简介
- TEKNO-MEDICAL Optik-Chirurgie GmbH
- Zimmer Biomet Holdings Inc.
- Integra Life Science
- B. Braun Melsungen AG
- Blink Medical Ltd
- Karl Storz
- Bolton Surgical Ltd
- Stanford Health Care
- Katena（Blink Medical Ltd）
第7章 市场机会今后动向
The oculoplastic surgery market is expected to register a CAGR of 5.5% during the forecast period.
Surgery markets across the world have been negatively impacted due to the disruptions experienced by their respective manufacturing and supply-chain operations as a result of precautionary lockdowns and other restrictions enforced by governing authorities across the globe. Moreover, consumer demand has also subsequently reduced as individuals are now more keen on eliminating non-essential expenses from their respective budgets as the general economic status of most people has been severely affected by the pandemic. The aforementioned factors are expected to burden the revenue trajectory of the global oculoplastic surgery market during the forecast period. This may be attributed to the increasing number of eye-related disorders, age-related oculoplastic surgeries, and technological advancements. For instance, in August 2021, as per the National Library of Medicine, contributors to the burden of eye disease at the global level are refractive errors (27.7 million DALYs), cataracts (17.7 million DALYs), macular degeneration (9.3 million DALYs), glaucoma (4.7 million DALYs), trachoma (1.3 million DALYs), etc. Thus, the increasing number of eye-related disorders is driving the growth of the market studied.
With the growing aging population, there would be an increase in disorders related to the face and eyelids, resulting in the market's growth. For instance, according to the World Health Organization, by 2030, one in six people in the world will be aged 60 years and above. At this time, the share of the population aged 60 years and above will increase from 1 billion in 2020 to 1.4 billion.
Key players operating in the market are focusing on submitting applications for the approval of intraocular lenses, oculoplastic surgery devices, etc., for use in ocular surgery, which is expected to drive the growth of the global oculoplastic surgery market over the forecast period. For instance, in April 2021, Bausch & Lomb Incorporated, a US-based eye health products company, received the United States Food and Drug Administration (FDA) approval for ClearVisc, a dispersive ophthalmic viscosurgical device (OVD) to be used in ocular surgery. ClearVisc contains sorbitol which protects from free radicals during cataract surgery. Moreover, in February 2021, Johnson & Johnson Vision announced that it received the United States Food and Drug Administration (FDA) approval for its TECNIS Eyhance Toric II monofocal intraocular lens (IOL) that can be used in cataract surgery of patients with or without astigmatism, an imperfection in the curvature of the eye.
However, the high cost of surgeries and lack of reimbursement policies may hamper the growth of the market to a certain extent.
Oculoplastic Surgery Market Trends
Eyelid Surgery in Oculoplastic Surgery is Expected to Witness a Healthy Growth in Future
The eyelid surgeries segment is expected to witness healthy growth in the future, attributed to the growing number of eyelid surgeries worldwide. For instance, as per the American Society of Plastic Surgeons, an estimated 1.3 million eyelid procedures were carried out globally in 2021. Eyelid surgeries are also called eyelifts and blepharoplasty, where an excess of skin is removed from the upper eyelid and reduces bagginess from the lower eyelid.
As per the American Society of Plastic Surgeons, eyelid surgery is often performed for cosmetic reasons. The source also revealed that blepharoplasty was one of the five most popular procedures among both men and women and the single most popular procedure among patients aged 65 and older. Blepharoplasty removes excess skin from the eyelids. With age, eyelids stretch, and the muscles supporting them weaken. As a result, excess skin and fat can gather above and below the eyelids. This can cause sagging eyebrows, droopy upper lids, and bags under the eyes. Besides aging, severely sagging skin around the eyes can reduce side vision (peripheral vision), especially the upper and outer parts of the visual field. Blepharoplasty can reduce or get rid of these vision problems. The surgery can also make the eyes look younger and more alert.
Thus, the advantages of eyelid surgery and the growing geriatric population are driving the growth of the market studied.
North America is Expected to Hold a Significant Share in the Market During the Forecast Period
North America is expected to hold a significant market share in the global oculoplastic surgery market due to the increasing aging population, rising disposable income, and willingness to spend on aesthetic surgeries. As per the American Society of Plastic Surgeons, in 2021, around 23 million plastic surgery procedures were performed in the United States, leading to a boost in the market in this region.
Rising awareness levels and developed healthcare infrastructure would raise the market in this region. An ophthalmologist performs LASIK surgery using a laser or microkeratome to reshape the eye's cornea and improve visual acuity. As of 2021, roughly 12 million Americans had LASIK. The prevalence of presbyopia was estimated at nearly 80% by ages 45-55 in North America, with an estimated 16.5% of these individuals without adequate correction.
Forty million people around the globe had LASIK surgery. In the United States, over ten million Americans have chosen to improve their vision and their quality of life with this treatment. In 2020, 718,000 people in the United States opted for LASIK surgery to ditch their eyeglasses or contacts.
Moreover, growing medical tourism, increasing healthcare expenditure, and the presence of well-established healthcare infrastructure are also greatly fueling the overall growth of the market in North America. In April 2021, as per the national library of medicine, many American patients visited South or Central American countries like Brazil, Argentina, or Costa Rica for cosmetic treatment, as they can travel cost-effectively and avail themselves of advanced cosmetic surgery. Mexico is a popular destination for American patients who need primary and dental care.
Thus, the aforementioned factors are boosting the growth of the market in the region.
Oculoplastic Surgery Market Competitor Analysis
The oculoplastic surgery market is moderately competitive and consists of several major players. Some of the companies that are currently dominating the market are Sklar Surgical Instruments, TEKNO-MEDICAL Optik-Chirurgie GmbH, Zimmer Biomet Holdings Inc., Integra Life Science, B. Braun Melsungen AG, Katena (Blink Medical Ltd), Karl Storz, Bolton Surgical Ltd, Stanford Health Care, and Blink Medical Ltd.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Increasing Number of Eye Related Disorder
- 4.2.2 Growing Number of Age-Related Oculoplastic Surgeries
- 4.2.3 Technological Advancement
- 4.3 Market Restraints
- 4.3.1 High Cost of Surgeries and Lack of Reimbursement
- 4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
- 5.1 By Procedure Type
- 5.1.1 Eyelid Surgery
- 5.1.2 Brow Lift and Forehead Lift
- 5.1.3 Facelift
- 5.1.4 Pediatric Oculoplastic surgery
- 5.1.5 Other Procedure Types
- 5.2 By End User
- 5.2.1 Hospitals
- 5.2.2 Ambulatory Surgical Centers
- 5.2.3 Other End Users
- 5.3 By Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
- 5.3.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 TEKNO-MEDICAL Optik-Chirurgie GmbH
- 6.1.2 Zimmer Biomet Holdings Inc.
- 6.1.3 Integra Life Science
- 6.1.4 B. Braun Melsungen AG
- 6.1.5 Blink Medical Ltd
- 6.1.6 Karl Storz
- 6.1.7 Bolton Surgical Ltd
- 6.1.8 Stanford Health Care
- 6.1.9 Katena (Blink Medical Ltd)
